The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
Open accessAbstract
Objective: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronary heart disease (CHD). We evaluated changes in the prevalence of cardiovascular risk factors (CVRFs) and 10‐year risk of CHD in a large cohort of HIV‐infected individuals. Methods: All individuals from the Swiss HIV Cohort Study (SHCS) who completed at least one CVRF questionnaire and for whom laboratory data were available for the period February 2000 to February 2006 were included in the analysis. The presence of a risk factor was determined using cut‐offs based on the guidelines of the National Cholesterol Education Program (NCEP ATP III), the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7), the American Diabetes Association, and the Swiss Society for Cardiology. Results: Overall, 8033 individuals completed at least one CVRF questionnaire. The most common CVRFs in the first completed questionnaire were smoking (57.0%), low high‐density lipoprotein (HDL) cholesterol (37.2%), high triglycerides (35.7%), and high blood pressure (26.1%). In total, 2.7 and 13.8% of patients were categorized as being at high (>20%) and moderate (10–20%) 10‐year risk for CHD, respectively. Over 6 years the percentage of smokers decreased from 61.4 to 47.6% and the percentage of individuals with total cholesterol >6.2 mmol/L decreased from 21.1 to 12.3%. The prevalence of CVRFs and CHD risk was higher in patients currently on ART than in either pretreated or ART‐naive patients. Conclusion: During the 6‐year observation period, the prevalence of CVRFs remains high in the SHCS. Time trends indicate a decrease in the percentage of smokers and individuals with high cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Highly active antiretroviral treatment (HAART) causes an increase of LDL-C and TG, and predominance of small, dense LDL particles, thus doubling their CAD risk when compared with HIV-negative subjects.212”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
El-Sadr, W. M., & The Data Collection On Adverse Events Of Anti-HIV Drugs (DAD) Study Group (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,677
Friis‐Møller, N., Weber, R. K., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Mateu, S., Law, M. G., et al. (2003) · AIDS · doi:10.1097/00002030-200305230-00010 · Cited by 1,076
Self-citationStandards of Medical Care in Diabetes
(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 688
Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 626
Mary‐Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. G. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 563
Flagged first, then by citations
1 of the 23 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Friis‐MollerN ReissP El SadrWet al. Exposure to PI and NNRTI and risk of myocardial infarction from the D. A. D. Study.13th Conference on Retroviruses and Opportunistic Infections. Denver CO February 2006 [Abstract 144].
- El SadrW NeatonJ NeuhausJ GordinF.Comparison of risk factors for coronary heart disease among men and women enrolled in the SMART Study (CPCRA 065).10th Conference on Retrovirus and Opportunistic Infections. Boston MA February 2003 [Abstract 745].
- GlassT VernazzaP WeberRet al. Predictors of successful cardiovascular risk factor management in HIV‐infected patients at moderate to high 10 years risk of coronary heart disease: The Swiss HIV Cohort Study.10th European AIDS Conference/EACS. Dublin Ireland November 2005 [Abstract PE9.5/8].
Cited by
Sorted by citations
Items 101–155 of 155
Human Immunodeficiency Virus Infection And Hypertension. Is There a Connection?
Sanidas, E. A., Papadopoulos, D. P., Velliou, M., Tsioufis, K., Barbetseas, J. D., & Papademetriou, V. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx208 · Cited by 8
Interarm Blood Pressure Differences in the Women's Interagency HIV Study
Lazar, J., Holman, S., MINKOFF, H. L., DeHovitz, J. A., & Sharma, A. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0237 · Cited by 8
Cardiovascular disease associated with human immunodeficiency virus: A review
Costa, L. A., & Almeida, A. G. (2015) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2015.06.008 · Cited by 8
Echeverría, P., Domingo, P., Llibre, J. M., Gutiérrez, M. D. M., Mateo, G. M., Puig, J., Bonjoch, A., Pérez‐Álvarez, N., Sirera, G., Clotet, B., et al. (2014) · BioMed Research International · doi:10.1155/2014/823058 · Cited by 7
Prevalence and risk factors of type II diabetes mellitus among people living with HIV in Texas
Buendia, J. R., Sears, S. C., Griffin, E., & Mgbere, O. O. (2021) · AIDS Care · doi:10.1080/09540121.2021.1925212 · Cited by 5
Tratamiento de las dislipemias en situaciones especiales
Goya, I. L., & Bueno, M. M. (2012) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(12)70042-0 · Cited by 6
Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms
Policarpo, S., Rodrigues, T., Moreira, A. C., & Valadas, E. (2019) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2018.10.012 · Cited by 5
VIH e doença coronária – quando a prevenção secundária é insuficiente
Carvalho, A. S., Valente, R. O., Morais, L. A., Daniel, P. M., Carvalho, R. S., Ferreira, L., & Ferreira, R. C. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.10.009 · Cited by 4
Autonomic Function is Associated with Fitness Level in HIV-Infected Individuals.
Kocher, M. H., Hetzler, R. K., Shikuma, C. M., Kimura, I. F., Stickley, C. D., Lindsey, R. A., Nakamoto, B. K., & Chow, D. C. (2015) · PubMed · Cited by 4
Factores de riesgo cardiovascular dependientes del paciente en población con infección por VIH
Portilla, J. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(09)73440-8 · Cited by 4
Premature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the Virus
Maisa, A., Westhorpe, C. L. V., Elliott, J., Jaworowski, A., Hearps, A. C., Dart, A. M., Hoy, J., & Crowe, S. M. (2010) · HIV Therapy · doi:10.2217/hiv.10.53 · Cited by 4
Cardiac Sequelae of Human Immunodeficiency Virus Disease
Alqaqa, A., Suleiman, A., Hamdan, A., Shamoon, F. E., Birnhak, S., Tariq, S., DeBari, V. A., & Sison, R. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000258 · Cited by 3
Lindayani, L., Purnama, H., Nurhayati, N., Sudrajat, D. A., & Taryudi, T. (2021) · SAGE Open Nursing · doi:10.1177/2377960821989135 · Cited by 3
“In addition, patients with HIV infection exhibit higher rates of conventional CVD risk factors compared to the general population such as smoking or drink alcohol, dyslipidemia, hypertension, and metabolic syndrome (Glass et al., 2006; Vance et al., 2011).”
BackgroundFerrari, É., SILVA, R. D., Bassichetto, K. C., & Lewi, D. S. (2009) · Cited by 2
Are Physical Fitness and CRP Related to Framingham Risk Score in HIV+ Adults?
Lewis, J. E., Poles, J., Garretson, E., Tiozzo, E., Goldberg, S., Campbell, C. S. G., Simões, H. G., Woolger, J. M., & Konefal, J. (2020) · American Journal of Lifestyle Medicine · doi:10.1177/1559827620904345 · Cited by 2
HIV and coronary disease – When secondary prevention is insufficient
Carvalho, A. S., Valente, R. O., Morais, L. A., Daniel, P. M., Carvalho, R. S., Ferreira, L., & Ferreira, R. C. (2017) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2016.10.019 · Cited by 2
Coronary Heart Disease in HIV-Infected Patients: Epidemiology
Mary‐Krause, M., & Costagliola, D. G. (2009) · Springer eBooks · doi:10.1007/978-88-470-0761-1_8 · Cited by 1
Ferrari, É., Filippelli-Silva, R., & Lewi, S. (2010) · Cited by 1
Cardiovascular Risk Factors Among People Being Treated for HIV in Nepal: A Cross-Sectional Study
Aryal, N., Marais, D., & Simkhada, P. P. (2014) · Journal of Clinical Research in HIV AIDS and Prevention · doi:10.14302/issn.2324-7339.jcrhap-12-157 · Cited by 1
Krämer, A., Lazzarotto, A. R., Sprinz, E., & Manfrói, W. C. (2009) · Cited by 1
Neumann, T., Sundermeyer, A., Esser, S., Potthoff, A., Hower, M., Becker-Boost, I., Ross, B., Jablonka, R., Neuhaus, K., Neumann, A., et al. (2010) · The Open Clinical Trials Journal · doi:10.2174/1876821001001020001 · Cited by 1
Sakthivel, M., Jayaseelan, V., Chinnakali, P., Hamide, A., Surendran, G., & Krishnamoorthy, Y. (2024) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_583_22 · Cited by 1
Cioe, P. A. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/585p-sn47 · Cited by 1
“STATE OF THE SCIENCE……………...………………………………..….......……1 Background and Significance……………………………………………..…...….3 HIV and Cardiovascular Disease………………………………………….3 HIV Infection and Cardiovascular Risk…………………………………...5 Cardiovascular Disease and Perceived Risk……………………………..14 Summary…………………………………………………………………………14 2.”
BackgroundMethodInfluentialHigh Prevalence of AH in HIV Patients on ART, in Bahia, Brazil
Vargas, D., Brites, C. R., Cotrim, H. P., & Daltro, C. (2020) · Current HIV Research · doi:10.2174/1570162x18666200620212547 · Cited by 1
Flexible marginal structural models for survival analysis
Xiao, Y. (2012) · eScholarship@McGill (McGill) · doi:10.82308/26320 · Cited by 1
Metabolic Alterations of HIV Infection
Silva, E. F. (2011) · InTech eBooks · doi:10.5772/20929
“The prevalence of hypertension in HIV-infected patients is around 25% (Glass et al., 2006; Jung et al., 2004,).”
BackgroundSevastianova, K. (2011) · Työväentutkimus Vuosikirja
Boccara, F., Meuleman, C., Éderhy, S., Lang, S., Janower, S., Cohen, A. A., & Raoux, F. (2009) · Springer eBooks · doi:10.1007/978-88-470-0761-1_9
Small Dense Low-density Lipoprotein and Cardiovascular Disease
Suh, S., & Lee, M. (2012) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2012.1.1.1
“것으로 알려져 있다.(46) 따라서 최근 유럽가이드라인에서는 HAART 치료중인 HIV 환자들에게 운동 및 식이조절과 함께 필요”
Coronary risk assessment in patients with HIV infection: why bother?
Möhlenkamp, S., Reinsch, N., Erbel, R., & Neumann, T. (2011) · International journal of cardiac imaging · doi:10.1007/s10554-011-9940-0
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Basil, C. B., Dosunmu, A., & Olatunji-Bello, I. I. (2016) · Journal of AIDS and HIV Research · doi:10.5897/jahr2015.0361
“This is contrary to other findings where 2 to 40% of HIV patients have been found to have diabetes (Brown et al., 2005, Hadigan et al., 2001; Glass et al., 2006).”
ResultLladó, L. I. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Renale Denervation als Therapieoption
Tölle, M., & van der Giet, M. (2013) · CardioVasc · doi:10.1007/s15027-013-0022-1
HIV infection and hypertension: Epidemiological and pathogenetic aspects
Manner, I. W. (2013) · NORA - Norwegian Open Research Archives
Bermúdez, E., & Patricia, J. (2015) · TDX (Tesis Doctorals en Xarxa)
Metabolic Disorders in Patients with HIV
Radu, F. I., Jipa, R. E., Rusu, E., Cursaru, R., Dragut, R., Stegaru, D., Gheorghiţă, A. G., & Radulian, G. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0046
“The prevalence of diabetes or milder glucose metabolism disorders in subjects with HIV has been reported in the range of 2-14% [28,29].”
BackgroundCardiovascular Risk in People Living with HIV/AIDS: Implications for Health Care
Reis, R. K., & Melo, E. S. (2015) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000513
Rare and Unusual Forms of Hypertension
Grossman, E., & Messerli, F. H. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50018-4
Radionuclide imaging of arterial inflammation in HIV-infected patients with vascular atherosclerosis
Korol, P., & Щербіна, О. В. (2019) · Radiation Diagnostics Radiation Therapy · doi:10.37336/2707-0700-2019-3-5
Rare and Unusual Forms of Hypertension
Grossman, E., & Messerli, F. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2766-1.00012-0
López-Márquez, F. C., Perez, A. A. M., Domingo, P., Robledo, A. I. U., Pérez, M. E. G., Galarza, F. F. G., Ruíz-Flores, P., & y Goytia, A. P. R. B. (2021) · Research Square · doi:10.21203/rs.3.rs-722713/v1
Pérez, A. A. M., Domingo, P., Robledo, A. I. U., Pérez, M. E. G., Galarza, F. G., Ruíz-Flores, P., y Goytia, A. P. R. B., & López-Márquez, F. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1273573/v1
Pahuja, M., & Selwyn, P. A. (2021) · doi:10.1093/med/9780198821328.003.0089
Pahuja, M., Merlin, J. S., & Selwyn, P. A. (2015) · doi:10.1093/med/9780199656097.003.0151
Núñez-González, J., Hernández, D. V., & Briceño, S. (2021) · Uno · doi:10.62349/revistauno.v.1i1.1
Coronary artery disease and human immunodeficiency virus
Sharma, T., Sharma, B., Chaudhary, R., Faraday, N. R., & Goldsweig, A. M. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103101
Charles, N., Nemeyimana, P., Fabrice, U., Emmanuel, T., Yvette, U., Nshimiyimana, T., Valens, K., Alain, I., Benon, T., Eliah, S., et al. (2025) · doi:10.56147/jidpc.2.1.7
Buendia, J. R., Sears, S. C., & Mgbere, O. (2022) · Figshare · doi:10.6084/m9.figshare.21162823
McMahon, C. N., Blanchard, E., & Samaras, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800769-3.00024-x
Metadata
- Authors
- Glass, T., Ungsedhapand, C., Wolbers, M., Weber, R., Vernazza, P., Rickenbach, M., Furrer, H., Bernasconi, E., Cavassini, M., Hirschel, B., Battegay, M., Bucher, H., & Study, T. S. H. C.
- Affiliations
- University Hospital of Basel (CH)
- University Hospital Zurich (CH)
- Kantonsspital St. Gallen (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- University Hospital of Bern (CH)
- Ospedale regionale di Lugano (CH)
- University Hospital of Geneva (CH)
- Venue
- HIV Medicine
- Publisher
- Wiley
- Published
- 2006-07-24
- Volume
- 7
- Issue
- 6
- Pages
- 404-410
- ISSN
- 1464-2662 (ISSN-L)
- 1468-1293
- OpenAlex
- W2068156414
- Cited by
- 156
- References
- 23
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 9 · 2018: 3 · 2017: 11 · 2016: 13 · 2015: 17 · 2014: 13 · 2013: 11 · 2012: 12
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- HIV Medicine (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- American Diabetes Association
- Cardiovascular Research Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cardiovascular risk factors, HIV infection, coronary artery disease, antiretroviral therapy, metabolic changes, smoking, hypercholesterolemia, HDL cholesterol, triglycerides, hypertension, 10-year cardiovascular risk, temporal trends, Swiss HIV Cohort Study
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Humans, Hypertension, Middle Aged, Surveys and Questionnaires, Risk Factors, Switzerland, Time Factors, Cohort Studies, HIV Infections, Prevalence, Practice Guidelines as Topic, Risk Assessment, Antiretroviral Therapy, Highly Active, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
